Document Detail


Comparative study of the ability of Leishmania mexicana promastigotes and amastigotes to alter macrophage signaling and functions.
MedLine Citation:
PMID:  20368344     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Leishmania alternates between two morphologically different stages, promastigotes and amastigotes. While the majority of reports focused on how the promastigote form can alter macrophage (Mphi) signaling and function, fewer reports investigated signaling alterations mediated by amastigotes, and there is a lack of comparative studies. In this study, we performed a comparison between the ability of both forms of the parasite to alter Mphi signaling and functions. Here, we show that both promastigotes and amastigotes were able to rapidly activate host protein tyrosine phosphatases (PTPs), importantly the Src homology 2 domain-containing PTP (SHP-1). However, we found that PTP-1B is specifically activated by promastigote but not amastigote infection and that lmcpb(-/-) promastigotes were no longer able to activate PTP-1B. We also show a similarity in the way promastigotes and amastigotes inactivate the transcription factors (TFs) STAT-1alpha and AP-1, but we show differences in the modulation of NF-kappaB, with promastigotes cleaving the p65 subunit, generating a smaller p35 subunit, and amastigotes fully degrading the p65 subunit with no p35 production. Importantly, we show that the cysteine proteinase LmCPb plays a key role in the alteration of NF-kappaB, STAT-1alpha, and AP-1 by promastigote and amastigote infections, ultimately leading to the inability of these TFs to translocate to the nucleus in response to gamma interferon (IFN-gamma) stimulation and thus contributing to the ability of both parasite forms to effectively block IFN-gamma-mediated nitric oxide (NO) production in Mphis.
Authors:
Issa Abu-Dayyeh; Kasra Hassani; Edze R Westra; Jeremy C Mottram; Martin Olivier
Related Documents :
8421174 - Correlates of leishmania-specific immunity in the clinical spectrum of infection with l...
2958844 - Involvement of the macrophage mannose-6-phosphate receptor in the recognition of leishm...
15003644 - A mixed th1/th2 response elicited by a liposomal formulation of leishmania vaccine inst...
1398944 - Leishmania donovani infection in scid mice: lack of tissue response and in vivo macroph...
14554094 - Human rotavirus specific t cells: quantification by elispot and expression of homing re...
12467364 - Susceptibility of reproduction in female pigs to impairment by stress and the role of t...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-04-05
Journal Detail:
Title:  Infection and immunity     Volume:  78     ISSN:  1098-5522     ISO Abbreviation:  Infect. Immun.     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-05-20     Completed Date:  2010-06-01     Revised Date:  2011-03-03    
Medline Journal Info:
Nlm Unique ID:  0246127     Medline TA:  Infect Immun     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2438-45     Citation Subset:  IM    
Affiliation:
Department of Microbiology and Immunology, McGill University, Montréal, QC, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cell Line
Cysteine Proteases / metabolism
Humans
Interferon-Stimulated Gene Factor 3 / antagonists & inhibitors
Interferon-gamma / immunology
Leishmania mexicana / immunology*,  pathogenicity*
Macrophages / immunology*,  parasitology*
Mice
Nitric Oxide / immunology
Protein Tyrosine Phosphatase, Non-Receptor Type 6 / metabolism
Protozoan Proteins / metabolism
Signal Transduction*
Transcription Factor AP-1 / antagonists & inhibitors
Transcription Factor RelA / metabolism
Grant Support
ID/Acronym/Agency:
WT 079356//Wellcome Trust; //Canadian Institutes of Health Research
Chemical
Reg. No./Substance:
0/Interferon-Stimulated Gene Factor 3; 0/Protozoan Proteins; 0/Transcription Factor AP-1; 0/Transcription Factor RelA; 0/gamma interferon activation factor; 10102-43-9/Nitric Oxide; 82115-62-6/Interferon-gamma; EC 3.1.3.48/Protein Tyrosine Phosphatase, Non-Receptor Type 6; EC 3.4.-/Cysteine Proteases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fine mapping of Leishmania major susceptibility Locus lmr2 and evidence of a role for Fli1 in diseas...
Next Document:  The C-terminal tail of Yersinia pseudotuberculosis YopM is critical for interacting with RSK1 and fo...